Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of electroporation to deliver DNA-based vaccines
D. N. Kisakov, Igor M. Belyakov, L.A. Kisakova, et al.
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 102-123
Open Access | Times Cited: 12

Showing 12 citing articles:

It won’t end with COVID: Countering the next phase of American antivaccine activism 2025–29
Peter J. Hotez
PLOS Global Public Health (2025) Vol. 5, Iss. 1, pp. e0004020-e0004020
Open Access
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial
Siyue Jia, Chengwei Shao, Xin Cheng, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses
Peter Pushko, Igor S. Lukashevich, Dylan M. Johnson, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 428-428
Open Access | Times Cited: 3
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Antibiotic-Free Gene Vectors: A 25-Year Journey to Clinical Trials
Corinne Marie, Daniel Scherman
Genes (2024) Vol. 15, Iss. 3, pp. 261-261
Open Access | Times Cited: 1
A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis
Ceren Gül, Aytül Gül, Tuğba Karakavuk, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126065-126065
Closed Access | Times Cited: 1
Nano-delivery platforms for bacterial gene transformation: suitability and challenges
Harkamal Kaur, Anu Kalia, Pooja Manchanda, et al.
International Microbiology (2024)
Closed Access | Times Cited: 1
Cationic cycloamylose based nucleic acid nanocarriers
Parteek Prasher, Mousmee Sharma, Vipul Agarwal, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111000-111000
Closed Access
Development of a genotype-matched Newcastle disease DNA vaccine candidate adjuvanted with IL-28b for the control of targeted velogenic strains of Newcastle disease virus in Africa
Charlie F. Amoia, Augustino A. Chengula, Jean N. Hakizimana, et al.
Veterinary Research Communications (2024) Vol. 49, Iss. 1
Open Access
Localized In Vivo Electro Gene Therapy (LiveGT)-Mediated Skeletal Muscle Protein Factory Reprogramming
James Hensley, Michael P. Francis, Alex Otten, et al.
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11298-11298
Open Access
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus
Philip Hicks, Tomaz B. Manzoni, Jonna B. Westover, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1403-1403
Open Access
Page 1

Scroll to top